Advances in Long-Acting Agents for the Treatment of HIV Infection.
Ontology highlight
ABSTRACT: Long-acting antiretroviral therapy holds the promise of new options for human immunodeficiency virus (HIV) treatment beyond the current paradigm of daily oral pills. Of particular interest is their potential role in addressing challenges with adherence to oral therapy and treatment fatigue. Similar to other conditions where long-acting formulations have proven effective such as contraception and mental health, long-acting antiretroviral therapy could provide additional treatment choices to people with HIV. This review provides an outline of the current landscape of long-acting antiretroviral therapy for HIV treatment, both approved and under development, including cabotegravir, rilpivirine, leronlimab, islatravir, albuvirtide, GS-6207, and broadly neutralizaing antibodies. However, there a
SUBMITTER: Rana AI
PROVIDER: S-EPMC7206978 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA